Cerebrospinal fluid tissue transglutaminase in vascular dementia

Journal of the Neurological Sciences

Volumn 203-204, Issue , 2002, Pages 207-209

  Bonelli, Raphael M ^a   Aschoff, Andreas ^b   Jirikowski, Gustaf ^b  

^a Hospital BHB Eggenberg   (Austria)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Alzheimer's disease; Apoptosis; Tau protein; Tissue transglutaminase; Vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN; BIOCHEMICAL MARKER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ALZHEIMER DISEASE; BRAIN REGION; CEREBROSPINAL FLUID ANALYSIS; CONFERENCE PAPER; HUMAN; HUNTINGTON CHOREA; IN VIVO STUDY; MULTIINFARCT DEMENTIA; NERVE CELL NECROSIS; PRIORITY JOURNAL;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DEMENTIA, VASCULAR; HUMANS; TAU PROTEINS; TRANSGLUTAMINASES;

EID: 0037111190     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00292-7     Document Type: Conference Paper

References (52)

1. Suh G.H., Shah A. A review of the epidemiological transition in dementia-cross-national comparisons of the indices related to Alzheimer's disease and vascular dementia. Acta Psychiatr. Scand. 104(1):2001;4-11.
2. Gold G., Bouras C., Canuto A.et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am. J. Psychiatry. 159(1):2002;82-87.
3. Stewart R. Vascular dementia: a diagnosis running out of time. Br. J. Psychiatry. 180:2002;152-156.
4. Gauthier S., Ferris S. Outcome measures for probable vascular dementia and Alzheimer's disease with cerebrovascular disease. Int. J. Clin. Pract., Suppl. 120:2001;29-39.
5. Andreasen N., Minthon L., Davidsson P.et al. Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch. Neurol. 58(3):2001;373-379.
6. Tapiola T., Pirttila T., Mehta P.D., Alafuzofff I., Lehtovirta M., Soininen H. Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease. Neurobiol. Aging. 21(5):2000;735-740.
7. Tapiola T., Pirttila T., Mikkonen M.et al. Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease. Neurosci. Lett. 280(2):2000;119-122.
8. Heininger K. A unifying hypothesis of Alzheimer's disease: IV. Causation and sequence of events. Rev. Neurosci. 11:2000;213-328.
9. Kang J., Lemaire H.G., Unterbeck A.et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325(6106):1987;733-736.
10. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 82(12):1985;4245-4249.
11. Delacourte A., Defossez A. Alzheimer's disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J. Neurol. Sci. 76(2-3):1986;173-186.
12. Kosik K.S., Joachim C.L., Selkoe D.J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 83(11):1986;4044-4048.
13. Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 8(1):1992;159-168.
14. Lee V.M., Balin B.J., Otvos L. Jr., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science. 251(4994):1991;675-678.
15. Johnson G.V., Cox T.M., Lockhart J.P., Zinnerman M.D., Miller M.L., Powers R.E. Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res. 751(2):1997;323-329.
16. Lesort M., Tucholski J., Miller M.L., Johnson G.V. Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog. Neurobiol. 61(5):2000;439-463.
17. Grierson A.J., Johnson G.V., Miller C.C. Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase. Neurosci. Lett. 298(1):2001;9-12.
18. Chun W., Lesort M., Tucholski J.et al. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells. Neurobiol. Dis. 8(3):2001;391-404.
19. Chun W., Lesort M., Tucholski J., Ross C.A., Johnson G.V. Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregates. J. Cell Biol. 153(1):2001;25-34.
20. Zemaitaitis M.O., Lee J.M., Troncoso J.C., Muma N.A. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 59(11):2000;983-989.
21. Aeschlimann D., Paulsson M. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J. Biol. Chem. 266(23):1991;15308-15317.
22. Aeschlimann D., Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thromb. Haemost. 71(4):1994;402-415.
23. Fesus L., Madi A., Balajthy Z., Nemes Z., Szondy Z. Transglutaminase induction by various cell death and apoptosis pathways. Experientia. 52(10-11):1996;942-949.
24. Fesus L., Davies P.J., Piacentini M. Apoptosis: molecular mechanisms in programmed cell death. Eur. J. Cell Biol. 56(2):1991;170-177.
25. Knight C.R., Rees R.C., Griffin M. Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim. Biophys. Acta. 1096(4):1991;312-318.
26. Citron B.A., SantaCruz K.S., Davies P.J., Festoff B.W. Intron-exon swapping of transglutaminase mRNA and neuronal tau aggregation in Alzheimer's disease. J. Biol. Chem. 29:2000;29.
27. Norlund M.A., Lee J.M., Zainelli G.M., Muma N.A. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease. Brain Res. 851(1-2):1999;154-163.
28. Thomazy V., Fesus L. Differential expression of tissue transglutaminase in human cells. An immunohistochemical study. Cell Tissue Res. 255(1):1989;215-224.
29. Ohashi H., Itoh Y., Birckbichler P.J., Takeuchi Y. Purification and characterization of rat brain transglutaminase. J. Biochem. (Tokyo). 118(6):1995;1271-1278.
30. Facchiano F., Benfenati F., Valtorta F., Luini A. Covalent modification of synapsin I by a tetanus toxin-activated transglutaminase. J. Biol. Chem. 268(7):1993;4588-4591.
31. Festoff B.W., Suo Z., Citron B.A. Plasticity and stabilization of neuromuscular and CNS synapses: interactions between thrombin protease signaling pathways and tissue transglutaminase. Int. Rev. Cytol. 211:2001;153-177.
32. Friedrich P., Fesus L., Tarcsa E., Czeh G. Protein cross-linking by transglutaminase induced in long-term potentiation in the Ca1 region of hippocampal slices. Neuroscience. 43(2-3):1991;331-334.
33. Ando M., Kunii S., Tatematsu T., Nagata Y. Rapid and transient alterations in transglutaminase activity in rat superior cervical ganglia following denervation or axotomy. Neurosci. Res. 17(1):1993;47-52.
34. Tucholski J., Lesort M., Johnson G.V. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience. 102(2):2001;481-491.
35. el Alaoui S., Mian S., Lawry J., Quash G., Griffin M. Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis). FEBS Lett. 311(2):1992;174-178.
36. Fesus L., Thomazy V., Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224(1):1987;104-108.
37. Anderson A.J., Su J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16(5):1996;1710-1719.
38. Cotman C.W., Anderson A.J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10(1):1995;19-45.
39. Melino G., Annicchiarico-Petruzzelli M., Piredda L.et al. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol. Cell. Biol. 14(10):1994;6584-6596.
40. Gentile V., Thomazy V., Piacentini M., Fesus L., Davies P.J. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J. Cell Biol. 119(2):1992;463-474.
41. Piredda L., Farrace M.G., Lo Bello M.et al. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J. 13(2):1999;355-364.
42. Autuori F., Farrace M.G., Oliverio S., Piredda L., Piacentini M. "Tissue" transglutaminase and apoptosis. Adv. Biochem. Eng. Biotechnol. 62:1998;129-136.
43. Oliverio S., Amendola A., Rodolfo C., Spinedi A., Piacentini M. Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis. J. Biol. Chem. 274(48):1999;34123-34128.
44. Aschoff A.P., Gunther E., Jirikowski G.F. Tissue transglutaminase in the small intestine of the mouse as a marker for apoptotic cells. Colocalization with DNA fragmentation. Histochem. Cell Biol. 113(4):2000;313-317.
45. Martinez M., Fernandez-Vivancos E., Frank A., De la Fuente M., Hernanz A. Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations. Brain Res. 869(1-2):2000;216-219.
46. Fesus L. Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes. Cell. Mol. Neurobiol. 18(6):1998;683-694.
47. Nemes Z., Fesus L., Egerhazi A., Keszthelyi A., Degrell I.M. N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. Neurobiol. Aging. 22(3):2001;403-406.
48. Folk J.E., Finlayson J.S. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv. Protein Chem. 31:1977;1-133.
49. Mattson M.P. Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 27(1):1992;29-49.
50. Miller M.L., Johnson G.V. Transglutaminase cross-linking of the tau protein. J. Neurochem. 65(4):1995;1760-1770.
51. Dudek S.M., Johnson G.V. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau. J. Neurochem. 61(3):1993;1159-1162.
52. Piacentini M., Autuori F. Immunohistochemical localization of tissue transglutaminase and Bcl-2 in rat uterine tissues during embryo implantation and post-partum involution. Differentiation. 57(1):1994;51-61.